News
-
-
PRESS RELEASE
Gerresheimer partners with RxCap to offer connected adherence solutions
Gerresheimer partners with RxCap to offer connected adherence solutions, enabling pharmacies to provide remote therapeutic monitoring and improve health outcomes. Gerresheimer's subsidiary Centor secures distribution rights for U.S. pharmacies -
-
-
-
-
-
PRESS RELEASE
Gerresheimer Decisively Continues on Profitable Growth Course in Financial Year 2023
Gerresheimer posts strong organic revenue growth of 10.4% and adjusted EBITDA growth of 17.5% in 2023. Favorable product mix and global capacity expansion drive profitable growth. Company's high order backlog and international production capacities set the stage for continued success -
-
PRESS RELEASE
Gerresheimer decisively continues on profitable growth course in financial year 2023
Gerresheimer reports strong financial results for 2023 with +10.4% organic revenue growth and +17.5% organic adjusted EBITDA growth. The company benefits from high demand for pens and favorable product mix